{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:01:18Z","timestamp":1762866078517},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jgyn.2012.09.023","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T19:45:19Z","timestamp":1352922319000},"page":"922-929","source":"Crossref","is-referenced-by-count":5,"title":["Suivi et conseils apr\u00e8s infections g\u00e9nitales hautes"],"prefix":"10.1016","volume":"41","author":[{"given":"E.","family":"Derniaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lucereau-Barbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2012.09.023_bib0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9378(75)90477-9","article-title":"Effect of acute pelvic inflammatory disease on fertility","volume":"121","author":"Westrom","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/OLQ.0b013e31821f918c","article-title":"Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study","volume":"38","author":"Trent","year":"2011","journal-title":"Sex Tansm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with Chlamydiae and Gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/168.4.969","article-title":"Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy","volume":"168","author":"Walker","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2011-050252","article-title":"Chlamydia trachomatis re-infections in a population-based cohort of women","author":"Liu","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpedi.162.11.1022","article-title":"Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease","volume":"162","author":"Trent","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.olq.0000135301.97350.84","article-title":"Prevention of Gonorrhea and Chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women","volume":"31","author":"Shain","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/AOG.0b013e318177143a","article-title":"Preventing recurrent sexually transmitted diseases in minority adolescents: a randomized controlled trial","volume":"111","author":"Thurman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.olq.0000143083.38684.9d","article-title":"Comparison of methods to increase repeat testing in persons treated for Gonorrhea and\/or Chlamydia at public sexually transmitted disease clinics","volume":"31","author":"Malotte","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial","volume":"186","author":"Ness","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0055","doi-asserted-by":"crossref","first-page":"30e1","DOI":"10.1016\/j.ajog.2007.05.021","article-title":"Do short term markers of treatment efficacy predict long term sequelae of pelvic inflammatory disease","volume":"198","author":"Trautmann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0060","first-page":"441","article-title":"Previous HIV testing among adults and adolescents newly diagnosed with HIV infection \u2013 National HIV Surveillance System, 18\u00a0jurisdictions, United States, 2006\u20132009","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0065","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1469-0705.1995.06060430.x","article-title":"Transvaginal sonography in suspected pelvic inflammatory disease","volume":"6","author":"Taipale","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1469-0705.1998.12010056.x","article-title":"Transvaginal sonographic markers of tubal inflammatory disease","volume":"12","author":"Timor-Tritsch","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0020-7292(85)90100-6","article-title":"Factors predicting abnormal hysterosalpingographic findings in patients treated for acute pelvic inflammatory disease","volume":"23","author":"Paavonen","year":"1985","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005637.pub2","article-title":"Prophylactic antibiotics for transcervical intrauterine procedures","volume":"18","author":"Thinkhamrop","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1701-2163(16)35222-7","article-title":"Antibiotic prophylaxis in gynaecologic procedures","volume":"34","author":"Van Eyk","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00404-002-0376-6","article-title":"Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole","volume":"268","author":"Heinonen","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1471-0528.1993.tb15308.x","article-title":"Morbidity following pelvic inflammatory disease","volume":"100","author":"Buchan","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s004040050123","article-title":"A study of second-look laparoscopy after acute salpingitis","volume":"258","author":"Gerber","year":"1996","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0110","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0029-7844(03)00695-1","article-title":"Lower quality of life among women with chronic abdominla pain after pelvic inflammatory disease","volume":"102","author":"Haggerty","year":"2003","journal-title":"Obstet gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2011.09.039","article-title":"The impact of chronic endometritis on reproductive outcome","volume":"96","author":"Kasius","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2105\/AJPH.94.8.1327","article-title":"Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease","volume":"94","author":"Ness","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0125","first-page":"219","article-title":"Effect of pelvic inflammatory disease on fertility","volume":"8","author":"Westrom","year":"1995","journal-title":"Venereology"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-0528.1986.tb08036.x","article-title":"Oral contraceptive use modifies the manifestations of pelvic inflammatory disease","volume":"93","author":"Wolner-Hanssen","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844\u00a0women with laparoscopically verified disease and 657\u00a0control women with normal laparoscopic results","volume":"19","author":"Westrom","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mob.2001.115114","article-title":"Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study","volume":"185","author":"Ness","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0145","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.contraception.2006.12.017","article-title":"Intrauterine devices \u2013 upper and lower genital tract infections","volume":"75","author":"Meirik","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(97)09086-7","article-title":"Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group","volume":"351","author":"Walsh","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00016340802707473","article-title":"Infection risk and intrauterine devices","volume":"88","author":"Martinez","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(00)04012-5","article-title":"Risk of clinical pelvic inflammatory disease attributable to an intrauterine device","volume":"357","author":"Shelton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.1990.tb02571.x","article-title":"Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use","volume":"97","author":"Buchan","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0180","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","article-title":"Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 comparative experience of levonorgestrel- and copper-releasing intrauterine devices","volume":"77","author":"Toivonen","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","article-title":"Health during prolonged use of levonorgestrel 20\u00a0micrograms\/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)","volume":"61","author":"Sivin","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0195","series-title":"Strat\u00e9gie de choix des m\u00e9thodes contraceptives chez la femme","author":"Anaes","year":"2004"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0200","series-title":"Crit\u00e8re de recevabilit\u00e9 pour l\u2019adoption et l\u2019utilisation des m\u00e9thodes contraceptives","author":"OMS","year":"2005"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0205","first-page":"1","article-title":"U S.\u00a0medical eligibility criteria for contraceptive use, 2010","volume":"18","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0010-7824(81)90086-X","article-title":"Influence of an intrauterine device on the course of an acute salpingitis","volume":"24","author":"Soderberg","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(77)90012-9","article-title":"Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease","volume":"15","author":"Larsson","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07853898909149184","article-title":"Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease","volume":"21","author":"Teisala","year":"1989","journal-title":"Ann Med"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(98)00064-X","article-title":"The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis","volume":"58","author":"Faundes","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0010-7824(99)00006-2","article-title":"Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates","volume":"59","author":"Morrison","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0235","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1471-0528.1990.tb01828.x","article-title":"Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion","volume":"97","author":"Sinei","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpediatrics.2010.256","article-title":"Adverse adolescent reproductive health outcomes after pelvic inflammatory disease","volume":"165","author":"Trent","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e3181557c25","article-title":"Chlamydia antibodies, Chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study","volume":"35","author":"Ness","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0250","first-page":"12","article-title":"Infertility: a global perspective. The role of pelvic infection","author":"Sciarra","year":"1994","journal-title":"ORGYN"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1155\/S106474499900023X","article-title":"Infertility following pelvic inflammatory disease","volume":"7","author":"Pavletic","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jcp.40.4.377","article-title":"Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction","volume":"40","author":"Robertson","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0265","first-page":"413","article-title":"Sexually transmitted diseases (STD) in adolescent girls","volume":"15","author":"Henry-suchet","year":"1987","journal-title":"Contracept Fertil Sex (Paris)"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/S1064744996000361","article-title":"Clinical consequences of immune response to CT upper genital tract infection in women","volume":"4","author":"Henry-Suchet","year":"1996","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.olq.0000162361.69041.a5","article-title":"Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease","volume":"32","author":"Haggerty","year":"2005","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00006254-199306000-00001","article-title":"The role of laparoscopy in chronic pelvic pain: promise and pitfalls","volume":"48","author":"Howard","year":"1993","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007435-200305000-00001","article-title":"A refined estimate of the average lifetime cost of pelvic inflammatory disease","volume":"30","author":"Yeh","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00007435-199609000-00007","article-title":"Decreasing incidences of Gonorrhea- and Chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden","volume":"23","author":"Kamwendo","year":"1996","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/sti.76.1.28","article-title":"Epidemiology of ectopic pregnancy during a 28\u00a0year period and the role of pelvic inflammatory disease","volume":"76","author":"Kamwendo","year":"2000","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0300","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1136\/bmj.316.7147.1776","article-title":"Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2307\/2136107","article-title":"The impact of a comprehensive Chlamydia prevention program in Wisconsin","volume":"27","author":"Hillis","year":"1995","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0310","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1258\/095646206777323436","article-title":"Trends in clinical encounters for pelvic inflammatory disease and epididymitis in a national sample of Australian general practices","volume":"17","author":"Chen","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0315","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/sti.2005.017186","article-title":"Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study","volume":"82","author":"Low","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0320","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0325","series-title":"\u00c9valuation du d\u00e9pistage des infections uro-g\u00e9nitales basses \u00e0 Chlamydia trachomatis en France","author":"Anaes","year":"2003"},{"key":"10.1016\/j.jgyn.2012.09.023_bib0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/095646202762226092","article-title":"The natural course of asymptomatic Chlamydia trachomatis infections: 45\u00a0% clearance and no development of clinical PID after one-year follow-up","volume":"13","author":"Morre","year":"2002","journal-title":"Int J STD AIDS"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036823151200261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036823151200261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T06:51:52Z","timestamp":1540104712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036823151200261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S036823151200261X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2012.09.023","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}